Achieve Life Sciences

ACHV

Market cap $223M

4.18 USD

-0.16

3.69%

At close Updated Jan 30, 4:00 PM EST

Pre-market

After hours

4.26

+0.08

1.91%

1 day

-3.69%

5 days

-23.86%

1 month

-11.06%

3 months

-20.23%

6 months

56.55%

Year to date

-15.9%

1 year

29.01%

5 years

-65.43%

10 years

-99.71%

About: Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Employees: 25

Healthcare Biotechnology